|
|
J P Palmer, D P Henry, J W Benson, D G Johnson, J W Ensinck
J Clin Invest. 1976;
57(2):522
doi:10.1172/JCI108305
Abstract |
Full text
| PDF

H
ypoglycemia stimulates immunoreactive glucagon (IRG) secretion and increases the activity of the sympathetic nervous system. To ascertain if the augmented alpha cell activity evoked by glucopenia is mediated by the adrenergic nervous system, the glucagon response to insulin-induced hypoglycemia of five subjects with neurologically complete cervical transections resulting from trauma, thereby disrupting their hypothalamic sympathetic outflow, was compared to six healthy volunteers. In addition to clinical neurological evaluation, completeness of sympathectomy was verified by failure to raise plasma norepinephrine levels during hypoglycemia compared to the two- and threefold increase observed in controls. Total IRG response (IRG area above basal 0-90 min) and peak IRG levels achieved were the same in the quadriplegics and the controls. Although the glucagon rise tended to be slower, and the peak levels attained occurred later in the quadriplegic patients than in the controls, this response was appropriate for their sugar decline, which was slower and reached the nadir later than in the control subjects. These observations that the glucagon release during insulin-induced hypoglycemia is normal in subjects whose hypothalamic sympathetic outflow has been interrupted provide strong evidence that the sympathetic nervous system does not mediate the glucagon response to hypoglycemia.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(17)
| Title and authors |
Publication |
Year |
Comprehensive Physiology
Philip E. Cryer
|
Comprehensive Physiology
|
2011 |
Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion
Kan Liu, Andrew J Paterson, Robert J Konrad, A.F Parlow, Shiro Jimi, Meejeon Roh, Edward Chin, Jeffrey E Kudlow
|
Molecular and Cellular Endocrinology
|
2002 |
Adrenoceptor antagonists, but not guanethidine, reduce glucopenia-induced glucagon secretion from perfused rat pancreas
Katsuhiko Ito, Hiroshi Hirose, Koichi Kido, Kazunori Koyama, Hiroshi Maruyama, Takao Saruta
|
Diabetes Research and Clinical Practice
|
1995 |
Hypoglycaemia unawareness in insulin-dependent diabetes mellitus
TH. F. VENEMAN, T. W. VAN HAEFTEN
|
European Journal of Clinical Investigation
|
1994 |
An Analysis of the Glucagon Response to Hypoglycaemia in Patients with Type 1 Diabetes and in Healthy Subjects
D. Liu, U. Adamson, P.-E. Lins, N. Clausen-Sjöbom
|
Diabetic Medicine
|
1993 |
Pancreatic and pituitary hormonal responses to insulin-induced hypoglycaemia during muscarinic cholinergic blockade in man
B. M. FISHER, D. A. HEPBURN, B. M. FRIER, J. J. MORTON, G. H. BEASTALLD, C. E. GRAY, K. D. BUCHANAN
|
European Journal of Clinical Investigation
|
1992 |
Preserved Insulin Secretion and Insulin Independence in Recipients of Islet Autografts
Kathryn L. Pyzdrowski, David M. Kendall, Jeffrey B. Halter, Raouf E. Nakhleh, David E.R. Sutherland, R. Paul Robertson
|
N Engl J Med
|
1992 |
Unawareness of Hypoglycaemia in Insulin-treated Diabetic Patients: Prevalence and Relationship to Autonomic Neuropathy
D.A. Hepburn, A.W. Patrick, D.W. Eadington, D.J Ewing, B.M. Frier
|
Diabetic Medicine
|
1990 |
Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion
B. Ahr�n, G. J. Taborsky, D. Porte
|
Diabetologia
|
1986 |
Hypoglycaemia and Diabetes
Brian M. Frier
|
Diabetic Medicine
|
1986 |
|